Market revenue in 2023 | USD 14.1 million |
Market revenue in 2030 | USD 17.2 million |
Growth rate | 2.9% (CAGR from 2023 to 2030) |
Largest segment | Cardiopulmonary perfusion system |
Fastest growing segment | Ex-Vivo Organ Perfusion System |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Cardiopulmonary Perfusion System, Cell Perfusion System, Ex-Vivo Organ Perfusion System |
Key market players worldwide | Getinge AB ADR, Medtronic PLC, LivaNova PLC, Terumo Corp, Nipro Corp, Fresenius Medical Care AG, Repligen Corp, Spectrum Brands Holdings Inc, Merck KGaA, Xvivo Perfusion AB |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to perfusion systems market will help companies and investors design strategic landscapes.
Cardiopulmonary perfusion system was the largest segment with a revenue share of 43.26% in 2023. Horizon Databook has segmented the Denmark perfusion systems market based on cardiopulmonary perfusion system, cell perfusion system, ex-vivo organ perfusion system covering the revenue growth of each sub-segment from 2018 to 2030.
The rapidly aging population and the rise in the prevalence of chronic diseases such as COPD are likely to drive the perfusion system market in Denmark. One of the main drivers of market expansion is the growing need for perfusion systems to control respiratory function.
Furthermore, the increased focus of manufacturers on the development and commercialization of safe & effective perfusion systems at low costs is expected to drive market growth during the forecast period. Moreover, Denmark’s healthcare system prioritizes value, compelling manufacturers and healthcare providers to validate the clinical & economic value of these products.
This dynamic landscape encourages the most effective and efficient solutions to thrive. In addition, a few major companies, such as LivaNova plc and Terumo Corporation, are anticipated to control a significant market share over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the Denmark perfusion systems market , including forecasts for subscribers. This country databook contains high-level insights into Denmark perfusion systems market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account